One has to wonder who checks the costing that Novartis uses to justify the price of its Kymriah Cancer Drug. What would Robert Koch, Louis Pasteur or Alexander Fleming make of this behaviour?
https://www.bloomberg.com//news/articles/2017-08-30/cancer-breakthrough-heralds-new-era-of-cures-costs-and-choices
Powell Admits Prior Monetary Framework Was Hugely Flawed
-
The Fed adjusted its Monetary Framework. Is it any better?
13 hours ago
No comments:
Post a Comment